• Neos Therapeutics to Present at Two Upcoming June Conferences

    المصدر: Nasdaq GlobeNewswire / 12 يونيو 2019 08:00:43   America/New_York

    DALLAS and FORT WORTH, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally disintegrating tablet (ODT) technology platforms, today announced that Jerry McLaughlin, its Chief Executive Officer, will present a company overview at two upcoming conferences in June.

    • The JMP Securities Life Sciences Conference on Wednesday, June 19, 2019 at 12:00 p.m. ET in New York, NY.
    • The BMO 2019 Prescriptions for Success Healthcare Conference on Tuesday, June 25, 2019 at 11:00 a.m. ET in New York, NY.

    A live webcast of both presentations will be available on the Investor Relations page of the company’s website at http://investors.neostx.com/. Following each presentation, a replay of the webcast will be available on Neos’ website for 30 days. 

    About Neos Therapeutics
    Neos Therapeutics, Inc. (NASDAQ: NEOS) is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Adzenys XR-ODT® (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING), Cotempla XR-ODT® (methylphenidate) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING), and Adzenys-ER® (amphetamine) extended-release oral suspension (see Full Prescribing Information, including Boxed WARNING), all for the treatment of ADHD, are three approved products using the Company’s extended-release  technology platform. Additional information about Neos is available at www.neostx.com.

    CONTACTS:

    Richard I. Eisenstadt
    Chief Financial Officer
    Neos Therapeutics
    (972) 408-1389
    reisenstadt@neostx.com

    Sarah McCabe
    Investor Relations
    Stern Investor Relations, Inc.
    (212) 362-1200
    sarah.mccabe@sternir.com

    Primary Logo

شارك على،